Medication Assisted Treatment

Course Overview

Harmful opioid(e.g., heroin, oxycodone and hydrocodone) use and opioid use disorders remains a critical national public health concern. There are several FDA-approved medications to assist in the treatment of opioid use disorders and each of these medications offers individuals a somewhat different approach to the treatment of their opioid use disorder.  This training will focus on enhancing treatment providers’ and community members’ understanding of the role of methadone, buprenorphine and oral and extended-release naltrexone in treating opioid use disorders.. The training will provide an overview of the research related to the use of these medications for both adults and young adults, as well as the practical issues related to providing coordinated care for individuals utilizing these medications as a treatment intervention. This training will also provide information about the use of the naloxone (Narcan) in the treatment of opioid overdose and as an overdose prevention tool.

Course Learning Objectives

Individuals participating in this training will:

• Increase understanding of opioid pharmacology.
   
• Learn the history of methadone, buprenorphine and naltrexone, including research into their safety and efficacy.
   
• Recognize how to use these medications in the provision of treatment for opioid use disorders.
   
• Increase understanding of coordinated care for individuals receiving medication-assisted treatment.
   
• Recognize and discuss barriers to the provision of medication assisted treatment.

Additionally, this training will also provide information about the use of the opioid antagonist medication naloxone in the treatment and prevention of opioid overdose.

When
Friday, June 19, 2015 through Friday, June 19, 2015
1 PM - 5 PM

Where
St. Charles Medical Center
Center for Health Learning
2500 NE Neff Road
Bend, OR  97701
See Map

Share

Add to Your Calendar